Department of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Department of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Curr Opin Virol. 2021 Jun;48:49-56. doi: 10.1016/j.coviro.2021.03.006. Epub 2021 Apr 20.
A central quest in gene therapy and vaccination is to achieve effective and long-lasting gene expression at minimal dosage. Adenovirus vectors are widely used therapeutics and safely deliver genes into many cell types. Adenoviruses evolved to use elaborate trafficking and particle deconstruction processes, and efficient gene expression and progeny formation. Here, we discuss recent insights into how human adenoviruses deliver their double-stranded DNA genome into cell nuclei, and effect lytic cell killing, non-lytic persistent infection or vector gene expression. The mechanisms underlying adenovirus entry, uncoating, nuclear transport and gene expression provide a blueprint for the emerging field of synthetic virology, where artificial virus-like particles are evolved to deliver therapeutic payload into human cells without viral proteins and genomes.
在基因治疗和疫苗接种中,一个核心问题是在最小剂量下实现有效和持久的基因表达。腺病毒载体被广泛用作治疗剂,可以安全地将基因递送到许多细胞类型中。腺病毒进化出了精细的运输和颗粒解构过程,以及高效的基因表达和后代形成。在这里,我们讨论了最近对人腺病毒如何将其双链 DNA 基因组递送到细胞核中,以及如何实现裂解性细胞杀伤、非裂解性持续感染或载体基因表达的深入了解。腺病毒进入、脱壳、核转运和基因表达的机制为新兴的合成病毒学领域提供了蓝图,在这个领域中,人工类似病毒的颗粒被进化用来将治疗性有效载荷递送到人类细胞中,而不使用病毒蛋白和基因组。